{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:20:44Z","timestamp":1789579244072,"version":"build-2803163510"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cidjournal.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.clindermatol.2015.11.012","type":"journal-article","created":{"date-parts":[[2015,11,22]],"date-time":"2015-11-22T06:50:08Z","timestamp":1448175008000},"page":"129-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Ocular changes induced by drugs commonly used in dermatology"],"prefix":"10.1016","volume":"34","author":[{"given":"Anna","family":"Turno-Kr\u0119cicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Grzybowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Misiuk-Hoj\u0142o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Patryn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Czajor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Nita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2015.11.012_bb0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00000441-196502000-00014","article-title":"The ocular toxicity of chloroquine therapy","volume":"249","author":"Giles","year":"1965","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0010","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/rheumatology\/36.7.799","article-title":"Antimalarial drugs in the treatment of rheumatological diseases","volume":"36","author":"Rynes","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archopht.1957.00930050463019","article-title":"Unusual ocular lesions in a case of systemic lupus erythematosus","volume":"57","author":"Cambiaggi","year":"1957","journal-title":"AMA Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0020","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(58)91911-1","article-title":"The ocular complications of chloroquine therapy","volume":"i","author":"Hobbs","year":"1958","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0025","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(59)90604-X","article-title":"Retinopathy following chloroquine therapy","volume":"i","author":"Hobbs","year":"1959","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/ard.41.1.52","article-title":"Chloroquine retinopathy: is there a safe daily dose?","volume":"41","author":"Marks","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0035","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0002-9394(68)91300-7","article-title":"Ocular toxicity of antimalarial drugs. Long-term follow-up","volume":"66","author":"Carr","year":"1968","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0040","first-page":"692","article-title":"Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity","volume":"12","author":"Finbloom","year":"1985","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0045","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/pgmj.59.692.343","article-title":"Adverse ocular reactions to drugs","volume":"59","author":"Spiteri","year":"1983","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0050","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/jm01240a021","article-title":"1,8-naphthyridine derivatives. A new class of chemotherapeutic agents","volume":"91","author":"Lesher","year":"1962","journal-title":"J Med Pharm Chem"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0738-081X(02)00322-X","article-title":"Quinolones in dermatology","volume":"21","author":"Sable","year":"2003","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9343(83)91267-6","article-title":"Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy","volume":"75","author":"Bernstein","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0065","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.icu.0000143688.45232.15","article-title":"Drug-induced corneal complications","volume":"15","author":"Hollander","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/02713683.2011.631719","article-title":"Chloroquine keratopathy of rheumatoid arthritis patients detected by in vivo confocal microscopy","volume":"37","author":"Ma","year":"2012","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00417-006-0365-8","article-title":"In vivo confocal microscopy in hydroxychloroquine-induced keratopathy","volume":"245","author":"Dosso","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0080","first-page":"368","article-title":"Keratopathy with low dose chloroquine therapy","volume":"57","author":"Cullen","year":"1986","journal-title":"J Am Optom Assoc"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0085","first-page":"36","article-title":"The cornea and synthetic antimalarials","volume":"17","author":"Jeddi","year":"1994","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0090","first-page":"249","article-title":"Is corneal deposition of antimalarial any indication of retinal toxicity?","volume":"25","author":"Easterbrook","year":"1990","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0095","first-page":"294","article-title":"Ocular toxicity of hydroxychloroquine","volume":"12","author":"Yam","year":"2006","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/ard.56.3.188","article-title":"Hydroxychloroquine and visual screening in a rheumatology outpatient clinic","volume":"56","author":"Grierson","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0105","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0161-6420(02)01168-5","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology","volume":"109","author":"Marmor","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0110","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0161-6420(98)99049-2","article-title":"Medications and cataract. The Blue Mountains Eye Study","volume":"105","author":"Cumming","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0002-9343(83)91268-8","article-title":"Ophthalmologic safety of long-term hydroxychloroquine sulfate treatment","volume":"75","author":"Rynes","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0120","author":"Scientific Department"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/0974-9233.106404","article-title":"Delayed onset chloroquine retinopathy presenting 10 years after long-term usage of chloroquine","volume":"20","author":"Kazi","year":"2013","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archderm.142.1.82","article-title":"Glucocorticoid-induced bone loss in dermatologic patients: an update","volume":"142","author":"Summey","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0140","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00055735-200012000-00016","article-title":"Ocular complications of topical, peri-ocular, and systemic corticosteroids","volume":"11","author":"Carnahan","year":"2000","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0145","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0190-9622(98)70573-0","article-title":"Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations","volume":"38","author":"Gilbertson","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00128071-200203030-00001","article-title":"Topical corticosteroid-induced adrenocortical insufficiency: clinical implications","volume":"3","author":"Levin","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0155","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/archderm.142.12.1568","article-title":"An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis","volume":"142","author":"Schlessinger","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0160","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1365-2133.2007.07753.x","article-title":"Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused","volume":"156","author":"Haeck","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0738-081X(02)00368-1","article-title":"The use of corticosteroids and corticosteroid phobia in atopic dermatitis","volume":"21","author":"Charman","year":"2003","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse effects of topical glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0175","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0140-6736(95)90324-0","article-title":"Cataracts, glaucoma, and femoral avascular necrosis caused by topical corticosteroid ointment","volume":"345","author":"McLean","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0180","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaad.2010.01.035","article-title":"Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts","volume":"64","author":"Haeck","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0185","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/jid.1967.29","article-title":"Regional variation in percutaneous penetration of 14 C cortisol in man","volume":"48","author":"Feldmann","year":"1967","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0190","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1525-1470.1988.tb00904.x","article-title":"Percutaneous absorption of hydrocortisone during and after the acute phase of dermatitis in children","volume":"5","author":"Turpeinen","year":"1988","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0195","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.exer.2008.10.004","article-title":"The role of steroids in outflow resistance","volume":"88","author":"Clark","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0200","first-page":"163","article-title":"Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature","volume":"17","author":"Jones","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0205","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00002512-199915060-00004","article-title":"Corticosteroids and glaucoma risk","volume":"15","author":"Tripathi","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0210","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2230.2004.01610.x","article-title":"Glaucoma induced by periorbital topical steroid use\u2014a rare complication","volume":"29","author":"Sahni","year":"2004","journal-title":"Clin Exp Dermatol"},{"issue":"Pt 5","key":"10.1016\/j.clindermatol.2015.11.012_bb0215","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/eye.1993.152","article-title":"Extensive visual loss with topical facial steroids","volume":"7","author":"Aggarwal","year":"1993","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0220","first-page":"238","article-title":"Corticosteroid-induced glaucoma following treatment of the periorbital region","volume":"99","author":"Katsushima","year":"1995","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0225","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1167\/iovs.02-1318","article-title":"Altered peripheral sensitivity to glucocorticoids in primary open-angle glaucoma","volume":"44","author":"Stokes","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0230","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0161-6420(00)00357-2","article-title":"Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon","volume":"107","author":"Ng","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0235","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00143888","article-title":"Periods of development of the normal human chamber angle","volume":"51","author":"Rem\u00e9","year":"1981","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0240","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0039-6257(86)90077-9","article-title":"Corticosteroid-induced cataracts","volume":"31","author":"Urban","year":"1986","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0245","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/bjo.66.5.290","article-title":"Ocular complications of systemic steroid after renal transplantation and their association with HLA","volume":"66","author":"Adhikary","year":"1982","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0250","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0272-6386(99)70414-2","article-title":"Incidence and long-term cost of steroid-related side effects after renal transplantation","volume":"33","author":"Veenstra","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0255","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1442-9071.1994.tb01696.x","article-title":"Ocular complications in renal transplant patients","volume":"22","author":"Matsunami","year":"1994","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0260","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1001\/archopht.1980.01020040625007","article-title":"Effect of corticosteroids on cataract formation","volume":"98","author":"Skalka","year":"1980","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0265","first-page":"69","article-title":"Atopic cataracts in a child with atopic dermatitis: a case report and review of the literature","volume":"18","author":"Chen","year":"2000","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0270","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archdermatol.2010.411","article-title":"Cataracts in atopic dermatitis: a case presentation and review of the literature","volume":"147","author":"Bair","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0275","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1001\/archderm.1994.01690110053006","article-title":"Abnormalities in serum lipids and leukocyte superoxide dismutase and associated cataract formation in patients with atopic dermatitis","volume":"130","author":"Niwa","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0280","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0039-6257(02)00338-7","article-title":"Central serous chorioretinopathy and glucocorticoids","volume":"47","author":"Bouzas","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0285","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9394(14)70531-8","article-title":"Choroidal capillary and venous congestion in central serous chorioretinopathy","volume":"121","author":"Pr\u00fcnte","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0290","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/bjo.79.10.922","article-title":"Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment","volume":"79","author":"Polak","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0295","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000027294","article-title":"Retinal pigment epithelial changes associated with systemic corticosteroid treatment: report of cases and review of the literature","volume":"212","author":"Spraul","year":"1998","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0300","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/S0161-6420(02)01117-X","article-title":"Corticosteroids and central serous chorioretinopathy","volume":"109","author":"Carvalho-Recchia","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0305","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/112067210901900204","article-title":"Comparison of dose-related ocular side effects during systemic isotretinoin administration","volume":"19","author":"Cumurcu","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0310","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-0960.2010.00657.x","article-title":"Adverse effects of isotretinoin: a retrospective review of 1743 patients started on isotretinoin","volume":"51","author":"Rademaker","year":"2010","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0315","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archopht.1986.01050180065031","article-title":"Abnormal retinal function associated with isotretinoin therapy for acne","volume":"104","author":"Weleber","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0320","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archdermatol.2012.352","article-title":"Ocular adverse effects of systemic treatment with isotretinoin","volume":"148","author":"Neudorfer","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0325","first-page":"1559","article-title":"Pathogenesis of blepharoconjunctivitis complicating 13-cis-retinoic acid (isotretinoin) therapy in a laboratory model","volume":"29","author":"Lambert","year":"1988","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0330","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1358\/dot.2004.40.1.799435","article-title":"Ocular side effects associated with isotretinoin","volume":"40","author":"Fraunfelder","year":"2004","journal-title":"Drugs Today"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0335","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/ICO.0b013e318183a396","article-title":"Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin","volume":"28","author":"Karalezli","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0340","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9394(01)01024-8","article-title":"Ocular side effects possibly associated with isotretinoin usage","volume":"132","author":"Fraunfelder","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0345","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1475-1313.2008.00590.x","article-title":"Drug-induced ocular side-effects with isotretinoin","volume":"28","author":"Santodomingo-Rubido","year":"2008","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0350","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00041327-200409000-00006","article-title":"Evidence for a probable causal relationship between tretinoin, acitretin, and etretinate and intracranial hypertension","volume":"24","author":"Fraunfelder","year":"2004","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0355","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2133.1991.tb06039.x","article-title":"Etretinate and visual function: a 1-year follow-up study","volume":"125","author":"Pitts","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0360","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0190-9622(99)70360-9","article-title":"Acitretin: optimal dosing strategies","volume":"41","author":"Ling","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0365","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2165\/0128071-200809060-00003","article-title":"Topical retinoids in acne vulgaris: update on efficacy and safety","volume":"9","author":"Thielitz","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0370","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4103\/0378-6323.57741","article-title":"Phototherapy: an update","volume":"75","author":"Rai","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0375","first-page":"801","article-title":"Psoralen-long-wave ultraviolet therapy and human cataractogenesis","volume":"23","author":"Lerman","year":"1982","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0380","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00162004","article-title":"A retrospective study of ocular findings in patients treated with PUVA","volume":"59","author":"Boukes","year":"1985","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0385","first-page":"173","article-title":"Lens opacities appearing during therapy with methoxsalen and long-wavelength ultraviolet radiation","volume":"19","author":"Lafond","year":"1984","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0390","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02150094","article-title":"8-methoxypsoralen and long ultraviolet effects on the rat lens: experiments with high dosage","volume":"218","author":"Koch","year":"1982","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0395","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaad.2007.04.027","article-title":"Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study","volume":"57","author":"Malanos","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0400","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2230.1989.tb02602.x","article-title":"Cutaneous and ocular side-effects of PUVA photochemotherapy\u2014a 10-year follow-up study","volume":"14","author":"Abdullah","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0405","first-page":"243","article-title":"Photochemotherapy and the eye: photoprotective factors","volume":"78","author":"Glew","year":"1980","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0410","first-page":"164","article-title":"Ocular side effects of PUVA-treated patients refusing eye sun protection","volume":"186","author":"Calzavara-Pinton","year":"1994","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.clindermatol.2015.11.012_bb0415","first-page":"94","article-title":"The demonstration of changes in bulbar conjunctiva surface epithelium in the psoriatic patients treated with PUVA","volume":"40","author":"S\u00f6ker","year":"2008","journal-title":"Ann Ophthalmol (Skokie)"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X15002370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X15002370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T19:55:05Z","timestamp":1567367705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X15002370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0738081X15002370"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2015.11.012","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular changes induced by drugs commonly used in dermatology","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2015.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}